Cargando…

Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review

IMPORTANCE: The economic impact of continuous professional development (CPD) education is incompletely understood. OBJECTIVE: To systematically identify and synthesize published research examining the costs associated with physician CPD for drug prescribing. EVIDENCE REVIEW: MEDLINE, Embase, PsycInf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cook, David A., Stephenson, Christopher R., Wilkinson, John M., Maloney, Stephen, Foo, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792887/ https://www.ncbi.nlm.nih.gov/pubmed/35080604 http://dx.doi.org/10.1001/jamanetworkopen.2021.44973

Ejemplares similares

Quality of cost evaluations of physician continuous professional development: Systematic review of reporting and methods
por: Cook, David A., et al.
Publicado: (2022)

Implementing a podiatry prescribing mentoring program in a public health service: a cost-description study
por: Couch, Anna G., et al.
Publicado: (2018)

Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis
por: Shaker, Marcus, et al.
Publicado: (2019)

Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States
por: Dixon, Dave L., et al.
Publicado: (2023)

Issues of cost-benefit and cost-effectiveness for simulation in health professions education
por: Maloney, Stephen, et al.
Publicado: (2016)

High value and low-cost virtual reality healthcare professional education: proceedings of a roundtable workshop
por: Walsh, Kieran, et al.
Publicado: (2020)

Breakeven, Cost Benefit, Cost Effectiveness, and Willingness to Pay for Web-Based Versus Face-to-Face Education Delivery for Health Professionals
por: Maloney, Stephen, et al.
Publicado: (2012)

Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates
por: Everson, Jordan, et al.
Publicado: (2020)

Association of Focused Medication Review With Optimization of Psychotropic Drug Prescribing: A Systematic Review and Meta-analysis
por: Sheehan, Rory, et al.
Publicado: (2018)

Simulation of Health and Economic Benefits of Extended Observation of Resolved Anaphylaxis
por: Shaker, Marcus, et al.
Publicado: (2019)

Continuing Professional Development via Social Media or Conference Attendance: A Cost Analysis
por: Maloney, Stephen, et al.
Publicado: (2017)

Mapping the Economic Costs and Benefits of Conservation
por: Naidoo, Robin, et al.
Publicado: (2006)

Cost of Inpatient Falls and Cost-Benefit Analysis of Implementation of an Evidence-Based Fall Prevention Program
por: Dykes, Patricia C., et al.
Publicado: (2023)

Prescribing patterns and economic costs of proton pump inhibitors in Colombia
por: Machado-Alba, Jorge, et al.
Publicado: (2013)

The Economics of Prescribing
por: Jennings, M.
Publicado: (1992)

Strategies for Containing Drug Costs: Implications for a Medicare Benefit
por: Cook, Anna E.
Publicado: (1999)

Economic Benefits and Costs Associated With Target Vaccinations
por: Armstrong, Edward P.
Publicado: (2007)

Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids
por: Chua, Kao-Ping, et al.
Publicado: (2019)

Comparison of a Prototype for Indications-Based Prescribing With 2 Commercial Prescribing Systems
por: Garabedian, Pamela M., et al.
Publicado: (2019)

Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration
por: Sankar, Ashwini, et al.
Publicado: (2021)

Cost Minimization Analysis of Same-Day Long-Acting Reversible Contraception for Adolescents
por: Wilkinson, Tracey A., et al.
Publicado: (2019)

Effect of Pharmacist Email Alerts on Concurrent Prescribing of Opioids and Benzodiazepines by Prescribers and Primary Care Managers: A Randomized Clinical Trial
por: Sacarny, Adam, et al.
Publicado: (2022)

Clinical Benefit, Price, and Uptake for Cancer Biosimilars vs Reference Drugs in China: A Systematic Review and Meta-Analysis
por: Luo, Xingxian, et al.
Publicado: (2023)

Back to the Land: Arthurdale, FDR's New Deal, and the Costs of Economic Planning
por: Maloney, C
Publicado: (2013)

Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials
por: Park, Jay J. H., et al.
Publicado: (2022)

Economic aspects of bladder cancer: what are the benefits and costs?
por: Sievert, K. D., et al.
Publicado: (2009)

Economic benefits and costs of surgery for filarial hydrocele in Malawi
por: Sawers, Larry, et al.
Publicado: (2020)

Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines
por: Jones, Christopher M., et al.
Publicado: (2023)

Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
por: Callender, Thomas, et al.
Publicado: (2021)

Estimated GFR reporting is associated with decreased nonsteroidal anti-inflammatory drug prescribing and increased renal function
por: Wei, Li, et al.
Publicado: (2013)

Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver
por: Lanham, Holly J., et al.
Publicado: (2022)

Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use
por: Streed, Carl G., et al.
Publicado: (2022)

Performance of 3 Sets of Criteria for Potentially Inappropriate Prescribing in Older People to Identify Inadequate Drug Treatment
por: Wallerstedt, Susanna M., et al.
Publicado: (2022)

Patterns in Nonopioid Pain Medication Prescribing After the Release of the 2016 Guideline for Prescribing Opioids for Chronic Pain
por: Goldstick, Jason E., et al.
Publicado: (2022)

Changes in Surgical Opioid Prescribing and Patient-Reported Outcomes After Implementation of an Insurer Opioid Prescribing Limit
por: Chua, Kao-Ping, et al.
Publicado: (2023)

Costs, Reach, and Benefits of COVID-19 Pandemic Electronic Benefit Transfer and Grab-and-Go School Meals for Ensuring Youths’ Access to Food During School Closures
por: Kenney, Erica L., et al.
Publicado: (2022)

Increases in Anti-infective Drug Prices, Subsequent Prescribing, and Outpatient Costs
por: Lee, Junsoo, et al.
Publicado: (2021)

Cost-effectiveness of Intermittent vs Continuous Pulse Oximetry Monitoring in Infants Hospitalized With Stabilized Bronchiolitis
por: Moretti, Myla E., et al.
Publicado: (2022)

Variations in Use of Diabetes Drugs With Cardiovascular Benefits Among Medicaid Patients
por: Zhai, Mike Z., et al.
Publicado: (2022)

Comparison of Prescribing Patterns Before and After Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia
por: Schaffer, Andrea L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vdogn2vl3tcbfliaepg4t1inm4